Computational Methods to Find and Rank MHC-I Restricted Tumor-Associated Antigens to Improve Therapeutic Efficacy and Tolerability of Antigen-based Cancer Immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2023
- Keyword
-
Antigenpräsentation
Tumorantigen
Immunreaktion
T-Lymphozyt
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2024
- Creator
- Contributor
-
Zaburdaev, Vasily
Vera González, Julio
- DOI
-
10.25593/open-fau-280
- URN
-
urn:nbn:de:101:1-2024011904052535555519
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lischer, Christopher
- Zaburdaev, Vasily
- Vera González, Julio
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2024
Other Objects (12)
Tolerance and immunity to human tumor-associated antigens
Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)
Tolerance and immunity tu human tumor-associated antigens
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy
Antibodies against tumor-associated antigens in early detection of colorectal cancer
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
Autoantibodies against tumor-associated antigens in the early detection of gastric cancer
Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma
TRPV1 nociceptors are required to optimize antigen-specific primary antibody responses to novel antigens
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens
Tolerance and immunity to human tumor-associated antigens
Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)
Tolerance and immunity tu human tumor-associated antigens
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy
Antibodies against tumor-associated antigens in early detection of colorectal cancer
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
Autoantibodies against tumor-associated antigens in the early detection of gastric cancer
Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma
TRPV1 nociceptors are required to optimize antigen-specific primary antibody responses to novel antigens
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens
Tolerance and immunity to human tumor-associated antigens
Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)
Tolerance and immunity tu human tumor-associated antigens
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy
Antibodies against tumor-associated antigens in early detection of colorectal cancer
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
Autoantibodies against tumor-associated antigens in the early detection of gastric cancer
Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma
TRPV1 nociceptors are required to optimize antigen-specific primary antibody responses to novel antigens